123707

Governed by California Health and Safety Code § 123707 , the Infant Botulism Treatment and Prevention Unit isn't just a regulatory body—it’s a manufacturer. It is the primary entity authorized to handle the distribution and licensure of Botulism Immune Globulin Intravenous (Human) , often referred to by its trade name, BabyBIG®.

In the quiet labs of the California Department of Public Health, a specialized team works under a unique legal mandate to solve a terrifying medical mystery: infant botulism. While rare, this condition can paralyze an infant’s muscles, making it impossible for them to breathe or eat. 123707

: To ensure rapid response, the department is exempt from standard competitive bidding for the testing and distribution of the treatment. Governed by California Health and Safety Code §

The law provides this unit with extraordinary flexibility because the stakes are so high. According to the statute: While rare, this condition can paralyze an infant’s

: Because cases of infant botulism can fluctuate by up to 60% annually , any unspent funds at the end of a fiscal year are automatically carried forward. This "rainy day" provision ensures that when an outbreak occurs, the resources are already in place.

The Sentinel of the Cradle: Inside California’s Lifesaving Botulism Unit

AI responses may include mistakes. For legal advice, consult a professional. Learn more California Code, Health and Safety Code - HSC § 123707